Prediction of Ipsilateral Lung Doses in Breast Radiotherapy by Anatomical Measurements Before Treatment Planning

OBJECTIVE To evaluate the predictive value of the patient’s anatomical measurements on ipsilateral lung doses before the whole breast radiotherapy (WBRT) planning. In planning WBRT, the ipsilateral lung is a major organ at risk. Prediction of lung doses can be helpful to choose the RT technique. METHODS Thoracic diameters, length and volume of the breast and ipsilateral lung, the height of the contralateral breast, and distance between two breasts were measured as anatomical parameters on the RT simulation computerized tomography (CT) images. Also, the ratios and differences of thoracic diameters were calculated. The correlation between the ipsilateral lung doses and anatomical parameters were evaluated in order to specify cut-off values that can predict high lung doses. RESULTS 102 patients who undergone breast-conserving surgery+WBRT were enrolled in this study. The anterior-posterior diameter of the thorax at the level of sternal notch (AP-Dnotch) and xiphisternal junction (AP-Dxiphi); the ratios of anterior-posterior and left-right diameters of the thorax (Rnotch and Rxiphi); the difference between AP-Dxiphi and AP-Dnotch (APDdiff) and the difference between the left-right diameters of the thorax at the level of sternal notch and xiphisternal junction (LRDdiff) were the statistically significant correlated parameters with lung doses. It can be predicted that the ipsilateral lung doses will be above average if the patients’ measurements are as AP-Dnotch

PDF

___

1. Sarrazin D, Lê MG, Arriagada R, Contesso G, Fontaine F, Spielmann M, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989;14(3):177–84.
2. Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98(4):697–702.
3. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 1992;(11):15–8.
4. Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992;(11):19–25.
5. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347(16):1233–41.
6. Winzer KJ, Sauer R, Sauerbrei W, Schneller E, Jaeger W, Braun M, et al; German Breast Cancer Study Group. Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 2004;40(7):998–1005.
7. Purdy JA. 3-D conformal radiotherapy: a new era in the irradiation of cancer. Basel, Switzerland: Karger; 1996. p. 1–16.
8. Rongsriyam K, Rojpornpradit P, Lertbutsayanukul C, Sanghangthum T, Oonsiri S. Dosimetric study of inverse-planed intensity modulated, forward-planned intensity modulated and conventional tangential techniques in breast conserving radiotherapy. J Med Assoc Thai 2008; 91(10):1571–82.
9. Schubert LK, Gondi V, Sengbusch E, Westerly DC, Soisson ET, Paliwal BR, et al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol 2011;100(2):241–6.
10.Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer R, et al. Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys 2010;76(1):287–95.
11.Liu H, Chen X, He Z, Li J. Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study. Comput Med Imaging Graph 2016;54:1–5.
12.Tsoutsou PG, Koukourakis MI. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 2006;66(5):1281–93.
13.Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 2013;85(2):444–50.
14.Vasiljevic D, Arnold C, Neuman D, Fink K, Popovscaia M, Kvitsaridze I, et al. Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study. Strahlenther Onkol 2018;194(6):520–32.
15. Oie Y, Saito Y, Kato M, Ito F, Hattori H, Toyama H, et al. Relationship between radiation pneumonitis and organizing pneumonia after radiotherapy for breast cancer. Radiat Oncol 2013;8:56.
16.Tsougos I, Mavroidis P, Rajala J, Theodorou K, Järvenpää R, Pitkänen MA, et al. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Phys Med Biol 2005;50(15):3535–54.
17.Werner ME, Eggert MC, Bohnet S, Rades D. Prevalence and Characteristics of Pneumonitis Following Irradiation of Breast Cancer, Anticancer Res 2019;39(11):6355–8.
18.Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for nonsmall cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys 1999;45(2):323–9.
19.Herrick JS, Neill CJ, Rosser PF. A comprehensive clinical 3-dimensional dosimetric analysis of forward planned IMRT and conventional wedge planned techniques for intact breast radiotherapy. Med Dosim 2008;33(1):62–70.
20. Mihai A, Rakovitch E, Sixel K, Woo T, Cardoso M, Bell C, et al. Inverse vs. forward breast IMRT planning. Med Dosim 2005;30(3):149–54.
21.Cardinale RM, Steele J, Fein DA, Mao L, Chon BH. The minimal dosimetric benefit of breast IMRT as compared to using a small number of forward planned MLC segments does not justify the cost (abstract 2629). Int J Radiat Oncol Biol Phys 2007;69(3 Suppl):553–4.
22.Hansen EK, Roach M. Handbook of evidence-based radiation oncology. 3rd ed. New York: Springer; 2018. p. 388.
23.Formenti SC, DeWyngaert JK, Jozsef G, Goldberg JD. Prone vs supine positioning for breast cancer radiotherapy. JAMA 2012;308(9):861–3.
24.Campana F, Kirova YM, Rosenwald JC, Dendale R, Vilcoq JR, Dreyfus H, et al. Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation. Int J Radiat Oncol Biol Phys 2005;61(5):1348–54.
25.Bishara AJ, Hittner JB. Testing the significance of a correlation with nonnormal data: Comparison of Pearson, Spearman, transformation, and resampling approaches. Psychological Methods 2012;17(3):399– 417.